Superparamagnetic iron oxide nanoparticles (SPIONs) have attracted attention in the
biomedical field thanks to their ability to prompt hyperthermia in response to an alternated …

Nanocarriers have therapeutic potential to facilitate drug delivery, including biological
agents, small-molecule drugs, and nucleic acids. However, their efficiency is limited by …

Bacteria can bypass the blood-brain barrier (BBB), suggesting the possibility of employment
of bacteria for combating central nervous system diseases. Herein, we develop a bacteria …

Glioblastoma multiforme (GBM) is a devastating tumor of the central nervous system,
currently missing an effective treatment. The therapeutic gold standard consists of surgical …

As an emerging cancer therapeutic target, non-apoptotic cell death such as ferroptosis,
necroptosis and pyroptosis, etc., has revealed significant potential in cancer treatment for …

The greatest obstacle to using drugs to treat brain tumors is the blood‐brain barrier (BBB),
making it difficult for conventional drug molecules to enter the brain. Therefore, how to safely …

Simple Summary Glioblastoma multiforme (GBM) are among the most lethal tumors. The
highly invasive nature and presence of GBM stem cells, as well as the blood brain barrier …

In recent years, the need for highly predictive brain cancer models to test new anticancer
compounds and experimental therapeutic approaches has significantly increased. Realistic …

Glioblastoma multiforme (GBM), also known as grade IV astrocytoma, represents the most
aggressive primary brain tumor. The complex genetic heterogeneity, the acquired drug …

Sonodynamic therapy (SDT) is a highly promising approach for cancer therapy, but its
efficacy is severely hampered by the low specificity of sonosensitizers and the unfavorable …